Penumbra Price to Free Cash Flow Ratio 2014-2022 | PEN
Historical price to free cash flow ratio values for Penumbra (PEN) since 2014.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Penumbra Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2023-02-03 |
261.02 |
|
0.00 |
| 2022-09-30 |
189.60 |
$-2.38 |
0.00 |
| 2022-06-30 |
124.52 |
$-1.06 |
0.00 |
| 2022-03-31 |
222.13 |
$-0.06 |
0.00 |
| 2021-12-31 |
287.32 |
$-0.31 |
0.00 |
| 2021-09-30 |
266.50 |
$-0.03 |
0.00 |
| 2021-06-30 |
274.06 |
$-1.03 |
0.00 |
| 2021-03-31 |
270.58 |
$-1.67 |
0.00 |
| 2020-12-31 |
175.00 |
$-1.62 |
0.00 |
| 2020-09-30 |
194.38 |
$-1.53 |
0.00 |
| 2020-06-30 |
178.82 |
$-0.95 |
0.00 |
| 2020-03-31 |
161.33 |
$-0.19 |
0.00 |
| 2019-12-31 |
164.27 |
$0.13 |
1311.01 |
| 2019-09-30 |
134.49 |
$0.32 |
424.93 |
| 2019-06-30 |
160.00 |
$0.20 |
809.72 |
| 2019-03-31 |
147.01 |
$0.19 |
783.64 |
| 2018-12-31 |
122.20 |
$0.53 |
229.61 |
| 2018-09-30 |
149.70 |
$0.24 |
614.53 |
| 2018-06-30 |
138.15 |
$0.24 |
578.03 |
| 2018-03-31 |
115.65 |
$0.26 |
452.46 |
| 2017-12-31 |
94.10 |
$0.00 |
0.00 |
| 2017-09-30 |
90.30 |
$-0.32 |
0.00 |
| 2017-06-30 |
87.75 |
$-0.51 |
0.00 |
| 2017-03-31 |
83.45 |
$-0.72 |
0.00 |
| 2016-12-31 |
63.80 |
$-0.79 |
0.00 |
| 2016-09-30 |
75.99 |
$-0.44 |
0.00 |
| 2016-06-30 |
59.50 |
$-2.20 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$9.913B |
$0.748B |
|
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
|
